Segment disclosures

Company overview

CEN BIOTECH INC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 12 retained observations 4 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Digital

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cenb:DigitalMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-31626867 USD20220414Open filing evidence
2021-07-01 – 2021-09-30272166 USD20211119Open filing evidence
2021-01-01 – 2021-09-30272166 USD20211119Open filing evidence
2020-01-01 – 2020-12-310 USD20220414Open filing evidence
2020-07-01 – 2020-09-300 USD20211119Open filing evidence
2020-01-01 – 2020-09-300 USD20211119Open filing evidence

Growth

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cenb:GrowthMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-310 USD20220414Open filing evidence
2021-07-01 – 2021-09-300 USD20211119Open filing evidence
2021-01-01 – 2021-09-300 USD20211119Open filing evidence
2020-01-01 – 2020-12-310 USD20220414Open filing evidence
2020-07-01 – 2020-09-300 USD20211119Open filing evidence
2020-01-01 – 2020-09-300 USD20211119Open filing evidence